Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study

被引：0
|
作者：
Ariel Berger
John Edelsberg
Vamsi Bollu
Jose Ma J Alvir
Ashish Dugar
Ashish V Joshi
Gerry Oster
机构：
[1] Policy Analysis Inc. (PAI),
[2] Novartis Pharmaceuticals Corporation,undefined
[3] Pfizer Inc.,undefined
来源：
BMC Psychiatry | / 11卷
关键词：
Fluoxetine; Generalize Anxiety Disorder; Sertraline; Venlafaxine; Index Date;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Cognitive predictors of healthcare utilization among anxiety disorder patients
    Dahlman, K
    Deacon, B
    Abramowitz, J
    DEPRESSION AND ANXIETY, 2005, 22 (04) : 208 - 209
  • [22] Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study
    Hudesman, David P.
    Chakravarty, Soumya D.
    Emond, Bruno
    Ellis, Lorie A.
    Lefebvre, Patrick
    Sadik, Kay
    Scher, Jose U.
    BMC RHEUMATOLOGY, 2020, 4 (01)
  • [23] Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study
    Chang, Hsien-Yen
    Kharrazi, Hadi
    Bodycombe, Dave
    Weiner, Jonathan P.
    Alexander, G. Caleb
    BMC MEDICINE, 2018, 16
  • [24] Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study
    Berger, Ariel
    Edelsberg, John
    Teal, Simon
    Mychaskiw, Marko A.
    Oster, Gerry
    BMC PULMONARY MEDICINE, 2012, 12
  • [25] Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study
    David P. Hudesman
    Soumya D. Chakravarty
    Bruno Emond
    Lorie A. Ellis
    Patrick Lefebvre
    Kay Sadik
    Jose U. Scher
    BMC Rheumatology, 4
  • [26] Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study
    Ariel Berger
    John Edelsberg
    Simon Teal
    Marko A Mychaskiw
    Gerry Oster
    BMC Pulmonary Medicine, 12
  • [27] Healthcare costs and utilization associated with high-risk prescription opioid use: A retrospective cohort study
    Chang H.-Y.
    Kharrazi H.
    Bodycombe D.
    Weiner J.P.
    Alexander G.C.
    BMC Medicine, 16 (1)
  • [28] THE EFFECT OF BROADENING GENERALIZED ANXIETY DISORDERS DEFINITION ON HEALTHCARE RESOURCES UTILIZATION AND COSTS: A COROLLARY FROM THE ADAN STUDY
    Carrasco, J. L.
    Alvarez, E.
    Olivares, J. M.
    Perez, M.
    Lopez-Gomez, V.
    de Salas, M.
    Rejas, J.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [29] Evidence-based pharmacotherapy of generalized anxiety disorder
    Baldwin, DS
    Polkinghorn, C
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2005, 8 (02): : 293 - 302
  • [30] Pharmacotherapy Update: Pregabalin in the Treatment of Generalized Anxiety Disorder
    Montgomery, Stuart A.
    Kasper, Siegfried
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 189 - 202
12345